Unraveling the link between frailty and Alzheimer's disease biomarkers in patients with mild cognitive impairment

Abstract

Background: Alzheimer's disease (AD) can be identified through biomarkers of amyloid (A) and tau (T) pathology. Frailty, a measure of biological aging, could impact the association between AD neuropathology and its clinical manifestation.